VIVE — Vivesto AB Share Price
0.000.00%
Last trade - 00:00- SEK164.64m
- SEK87.60m
- 10
- 32
- 68
- 27
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.83 | ||
| Price to Tang. Book | 2.85 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -66.82% | ||
| Return on Equity | -49.21% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | 1.98 | 201.84 | 26.19 | 1.01 | n/a | 13 | 24 | -100% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Vivesto AB, formerly Oasmia Pharmaceutical AB is a Swecen-based pharma company that develops new treatment options for patients suffering from difficult-to-treat cancer. The company has a growing portfolio of projects in the clinical phase focused on advanced cancer. Apealea (paclitaxel micellar) is being developed for patients with ovarian cancer through a partnership with Elevar Therapeutics, Inc. Other development programs include Cantrixil, a clinical program in advanced ovarian cancer, and docetaxel micellar, which is being developed for widespread prostate cancer. Vivesto's patented technology platform is developed to improve the water solubility, efficacy and safety of drugs.
Directors
- Anders Harfstrand NEC (65)
- Francois Martelet CEO (58)
- Fredrik Jarrsten CFO (54)
- Elin Trampe CTO (41)
- Reinhard Koenig CSO (61)
- Heidi Ramstad OTH (52)
- Peter Selin OTH (48)
- Peter Zonabend DRC (41)
- Hege Hellstrom IND (56)
- Birgit Norinder IND (73)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- September 22nd, 1988
- Public Since
- December 30th, 2005
- No. of Shareholders
- 18,293
- No. of Employees
- 14
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- OMX Nordic Exchange Stockholm
- Shares in Issue
- 538,043,455
- Address
- Gustav III:s Boulevard 46, 5tr, SOLNA, 169 73
- Web
- https://www.vivesto.com/
- Phone
- +46 18505440
- Auditors
- KPMG AB
Upcoming Events for VIVE
Q1 2024 Vivesto AB Earnings Release
Vivesto AB Annual Shareholders Meeting
Q2 2024 Vivesto AB Earnings Release
Similar to VIVE
Biogaia AB
OMX Nordic Exchange Stockholm
BoneSupport Holding AB
OMX Nordic Exchange Stockholm
Calliditas Therapeutics AB
OMX Nordic Exchange Stockholm
Camurus AB
OMX Nordic Exchange Stockholm
Cline Scientific AB
OMX Nordic Exchange Stockholm
FAQ
What is the Vivesto AB share price?
As of Today at 19:23 UTC, shares in Vivesto AB are trading at SEK0.31. This share price information is delayed by 15 minutes.
How has the Vivesto AB share price performed this year?
Shares in Vivesto AB last closed at SEK0.31 and the price had moved by -12.57% over the past 365 days. In terms of relative price strength the Vivesto AB share price has underperformed the FTSE Global All Cap Index by -19.67% over the past year.
What are the analyst and broker recommendations for Vivesto AB?
The overall consensus recommendation for Vivesto AB is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Vivesto AB dividend yield?
Vivesto AB does not currently pay a dividend.
Does Vivesto AB pay a dividend?
Vivesto AB does not currently pay a dividend.
When does Vivesto AB next pay dividends?
Vivesto AB does not currently pay a dividend.
How do I buy Vivesto AB shares?
To buy shares in Vivesto AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Vivesto AB?
As of the previous close price of SEK0.31, shares in Vivesto AB had a market capitalisation of SEK164.64m.
Where are Vivesto AB shares listed?
Here are the trading details for Vivesto AB:
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: VIVE
What kind of share is Vivesto AB?
Based on an overall assessment of its quality, value and momentum Vivesto AB is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Vivesto AB share price forecast for 2024?
The analyst consensus target price for shares in Vivesto AB is SEK1.00. That is 226.8% above the last closing price of SEK0.31.
Analysts covering Vivesto AB currently have a consensus Earnings Per Share (EPS) forecast of -SEK0.25 for the next financial year.
What is the trend in the Vivesto AB share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Vivesto AB. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +39.22%.
As of the last closing price of SEK0.31, shares in Vivesto AB were trading +11.44% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Vivesto AB PE Ratio?
The Vivesto AB PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SEK0.31.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Vivesto AB?
Vivesto AB's management team is headed by:
- Anders Harfstrand - NEC
- Francois Martelet - CEO
- Fredrik Jarrsten - CFO
- Elin Trampe - CTO
- Reinhard Koenig - CSO
- Heidi Ramstad - OTH
- Peter Selin - OTH
- Peter Zonabend - DRC
- Hege Hellstrom - IND
- Birgit Norinder - IND